Utah gives startup Nolla Health permission to start issuing AI automated prescriptions for acne treatments
SiliconANGLE Mike Wheatley ● Covered by 2 sources
Utah just let Nolla Health use AI to approve acne prescriptions with only limited doctor oversight. It’s the first U.S. sandbox for this kind of automated prescribing.
Based on reporting by SiliconANGLE, Mike Wheatley — read the original for the full story.
Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error
Utah has handed Nolla Health permission to try something that, until now, sat squarely in a doctor’s lane: letting an AI approve acne prescriptions. The startup says its app can take a photo of a face, ask a few questions, and then choose a treatment without the patient ever speaking to a physician. For now, the state is treating it as a pilot, not a free-for-all.
The app, Nolla Derm, runs on iPhones and uses an AI model to pick from a short list of physician-approved topical treatments. If a request falls outside the system’s limits, it gets kicked to a licensed human doctor. Patients first go through an intake process, then upload a facial scan, and the app sends the prescription to a local pharmacy or to the home. It also keeps scanning day by day and updates the treatment plan each month.
The approval came through Utah’s AI Learning Lab sandbox program, with backing from the Utah Office of Artificial Intelligence Policy, the Utah Division of Professional Licensing, the Utah Medical Association and the American Academy of Dermatology. Utah is also careful to say the sandbox is not an endorsement. The state’s own language says participation does not mean it has approved, certified or vouched for the product.
The pilot itself is staged. In the first phase, two physicians sign off on every AI-generated prescription until at least 100 patients have gone through without serious problems. Then the system moves to a second phase covering 500 patients, where the AI issues prescriptions directly and doctors review them afterward. In the third phase, physicians review at least 10% of automated prescriptions each month.
Nolla says this is just the opening act. Chief Medical Adviser Zaid Fadul told Inc.com the company wants to move beyond dermatology if the pilot works, and pointed to conditions like the flu and uncomplicated urinary tract infections. He also drew a line around the darker side of automation: no serious diagnoses, no major procedures, and no high-risk drugs like stimulants, opioids and benzodiazepines.
My take — AI-written commentary, not fact-checked reporting
This is the right kind of AI experiment: narrow, supervised, and stuck inside guardrails instead of pretending it can do medicine by vibes. Utah gets points for making the sandbox sound like a sandbox, not a stamp of approval. The real test is whether companies can keep the scope this tidy once the press release glow fades.
Read more about this at: SiliconANGLE